Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05977686 · ClinicalTrials.gov registry record

Hemoglobin Testing in Pregnant Patients

A clinical trial of Post Partum Hemorrhage and Anemia of Pregnancy, sponsored by George Washington University.

Recruiting
Registry status
200
Enrollment target
2
Study locations

NCT05977686 is a study of Post Partum Hemorrhage and Anemia of Pregnancy that is actively recruiting participants, run by George Washington University. The registered enrollment target is 200 participants, below the 1,768-participant average among 7 other Post Partum Hemorrhage trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05977686, a study of Post Partum Hemorrhage and Anemia of Pregnancy, is actively recruiting participants, sponsored by George Washington University.

RECRUITING
Registry status
200 participants
Enrollment target
2
Study locations

Study Summary

The project is a prospective observational study aimed to assess and to validate the use of point-of-care hemoglobin testing in pregnancy. Point-of-care hemoglobin testing has the potential to (1) increase access to hemoglobin monitoring in pregnancy in low resource settings, (2) increase availability of hemoglobin monitoring in anemic patients, and (3) provide immediate results for real-time patient counseling and intervention. However, to date, point-of-care hemoglobin testing devices have not yet been studied for use in an ambulatory obstetric population. The Masimo device is a Root Radical 7 Pulse CO-Oximeter, manufactured by Masimo, Inc. This device is non-invasive and placed externally on a patient's finger to generate an estimation of a patient's hemoglobin value. The HemoCue® device is a minimally-invasive device that relies on the finger prick method to get a capillary hemoglobin measurement, and The Rubby is a mobile application based platform that uses a photo of the participants nailbed to estimate hemoglobin values. Participants in this study will be approached at the Obstetrics and Gynecology clinics at George Washington Medical Faculty Associates. Point-of-care hemoglobin measurements will be assessed using the non-invasive Masimo device along with minimally-invasive hemoglobin HemoCue® Hb 801 device and compared to traditional venipuncture hemoglobin testing.

Conditions Studied

Post Partum Hemorrhage Anemia of Pregnancy

Interventions

  • DEVICE Masimo Root Radical 7 Pulse CO-Oximeter
  • DEVICE HemoCue Hb 801

Study Locations (2)

District of Columbia

  • George Washington University - Washington D.C.

Virginia

  • Inova Health System - Falls Church

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-12-03
Est. Completion 2026-12

Sponsor

George Washington University

133 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05977686

The ClinicalTrials.gov registry entry for NCT05977686 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,768-participant average among 7 other Post Partum Hemorrhage trials with a reported enrollment target (89% lower). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Post Partum Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Masimo Root Radical 7 Pulse CO-Oximeter is the first listed.

NCT05977686 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Virginia.

Frequently Asked Questions

What is clinical trial NCT05977686 about?

NCT05977686 is a clinical study titled "Hemoglobin Testing in Pregnant Patients". The project is a prospective observational study aimed to assess and to validate the use of point-of-care hemoglobin testing in pregnancy. Point-of-care hemoglobin testing has the potential to (1) increase access to hemoglobin monitoring in pregnancy in low resource settings, (2) increase availabili...

What is the current status of trial NCT05977686?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-12-03. Estimated completion is 2026-12.

What conditions does trial NCT05977686 study?

This clinical trial studies the following conditions: Post Partum Hemorrhage, Anemia of Pregnancy.

What interventions are being tested in trial NCT05977686?

The interventions under investigation include: Masimo Root Radical 7 Pulse CO-Oximeter (DEVICE), HemoCue Hb 801 (DEVICE).

Who is sponsoring clinical trial NCT05977686?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05977686 being conducted?

This trial has 2 study locations across District of Columbia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post Partum Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Post Partum Hemorrhage

All registered trials for this condition

Anemia of Pregnancy

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.